{
  "docId": "019dd923-5ddf-7308-8fca-9a18b30a43c1",
  "docSlug": "ce62d3d978381f05",
  "documentTitle": "Trend 2030 Dynamic Technology Innovation",
  "authorId": "RolandBerger",
  "authorName": "Roland Berger",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.445,
  "pageNumber": 18,
  "pageCount": 49,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "industry_trends",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a bulleted list to provide country-specific insights on market dynamics and challenges.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ddf-7308-8fca-9a18b30a43c1/18",
  "deckHref": "/decks/019dd923-5ddf-7308-8fca-9a18b30a43c1",
  "deckJsonHref": "/decks/019dd923-5ddf-7308-8fca-9a18b30a43c1.json",
  "deckAnchorHref": "/decks/019dd923-5ddf-7308-8fca-9a18b30a43c1#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.07,
        "y": 0.93
      },
      "kind": "disclaimer",
      "text": "1) Patent Cooperation Treaty: Intellectual property rights enforced in 148 countries worldwide",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1001b796-e71d-4174-9bec-fada29577f23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.6,
        "x": 0.07,
        "y": 0.97
      },
      "kind": "disclaimer",
      "text": "Source: WEF, Global Data, PwC, Forbes, IBIS World, Evaluate Group, USDA, JLL, Deloitte, BCNet Staff, EY, World Bank, IMS Health",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e6a7526-eead-4ec4-b858-a0b948242ed4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.58
      },
      "kind": "list",
      "text": "Brazil is the biggest Life Sciences market in Latin American today with strong growth rates, especially regarding pharmaceuticals (generics in particular). Green biotech innovation can help increase crop yields.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13de1f15-6524-47c4-bc97-25aeeed6d642",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.07,
        "y": 0.68
      },
      "kind": "list",
      "text": "Indonesia, as the world's 4th most populated country and a GDP below 4.000 USD PPP per capita, strongly depends on progress in Life Sciences. Latest policies aim at reducing Indonesia's high raw materials import dependency (currently 90%).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3441c0f0-b1dd-4ab5-a5d4-257b876e78e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.07,
        "y": 0.23
      },
      "kind": "list",
      "text": "The majority of today's Life Sciences markets is centered around industrial countries, especially USA, Japan and Europe. For example, industrial countries account for 70% of the global pharmaceutical market.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5eec8be-fef7-44b8-974f-1d1596ba6774",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.07,
        "y": 0.34
      },
      "kind": "list",
      "text": "Chinese companies will become global players in Life Sciences as domestic consolidation progresses. China's pharma sales value has surpass Japan's, becoming the second biggest pharma market worldwide.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5dadcad-79b9-462e-98d1-1b4988146777",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.07,
        "y": 0.46
      },
      "kind": "list",
      "text": "Although a latecomer, India possesses great potential, provided that its government takes action on broader healthcare access. Currently India ranks fourth in the world among the highest generic pharmaceuticals producers.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3fae5d4-605a-46bb-8679-cb923fcb1a11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.11
      },
      "kind": "title",
      "text": "Emerging countries in particular face major challenges which can be addressed with enhanced capabilities in Life Sciences",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae1a6746-9abd-4a76-8727-0fb03f1c7043",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "a042daa5-f3b2-4161-9d9c-725518e48549",
      "evidence": "The slide discusses specific countries and their Life Sciences markets, indicating an understanding of the target audience.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 44,
      "from": 16,
      "beatId": "c88790bb-1473-4650-84da-8a3019f02d31",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document provides satisfaction by outlining solutions and guidance.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 44,
      "from": 6,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "aa680251-185f-4185-8b89-7088310af07a",
      "evidence": "The document uses the golden circle to explain innovation.",
      "position": 0,
      "objective": "Why, what, and how of innovation",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 30,
      "from": 15,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "549f2af1-8162-4789-ab2c-fce0705dbfd8",
      "evidence": "The document highlights the costs of inaction in innovation.",
      "position": 1,
      "objective": "Consequences of not innovating",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}